top of page

PROGRAM

Depending on the situation, the schedule and presentation titles might be changed.

8th May, 2019, Chiba University

 

8:30 ~

 

Registration

9:20 ~ 9:30

Opening Remarks

Mariko Shiba (National Cerebral and Cardiovascular Center Research Institute)

President of The Japanese Society of Gene Design and Delivery

 

9:30 ~ 9:35

Greeting

Hidetaka Akita (Graduate School of Pharmaceutical Sciences, Chiba University)

Organizer of 19th Symposium for Gene Design and Delivery

9:35 ~ 9:55

Opening Lecture

"Polysaccharide/DNA Complexes to Deliver Therapeutic Oligonucleotides to Immunocytes"

Kazuo Sakurai (Faculty of Environmental Engineering, The University of Kitakyushu)

Vice-President of The Japanese Society of Gene Design and Delivery

9:55 ~ 10:55

Special Lecture  

"Novel approaches to overcome rare diseases: preadipocyte-based gene therapy and iPS cells from progeroid syndrome"

Koutaro Yokote (Graduate School of Medicine‚ Chiba University)

        

                                         

10:55 ~ 11:40

Invited Lecture 1

“Utilizing naturally occurring extracellular vesicles for gene delivery “

Sherry Wu (School of Biomedical Sciences, The University of Queensland)

11:50~ 12:50

Luncheon Seminar

"ロボット生物学の今とこれから ~Life Science with Robot~"

Genki Kanda (RIKEN Center for Biosystems Dynamics Research; RBI Inc.)

*This seminar will be demonstrated by Japanese.

 

13:00 ~ 14:30

Poster session

 (13:00 ~ 13:45)  Odd number

 (13:45 ~ 14:30)  Even number

 

14:40 ~ 14:50

General Meeting

14:55 ~ 15:40

Invited Lecture 2

"Tumor-associated lymphatic vessels at the interface of immunity and metastasis"

Amanda W. Lund (Department of Cell, Developmental and Cancer Biology, Oregon Health and Science University)

 

15:40 ~ 16:15

 

Invited Lecture 3

"Mutation-derived neoantigens as a promising target for cancer vaccine development"

Hirokazu Matsushita (Aichi Cancer Center Research Institute)

16:15~16:25

Break

16:25 ~ 17:00

Invited Lecture 4

"Novel Liposomal Gemcitabine, FF-10832, Improves Gemcitabine Pharmacokinetics (PK) and Increases Anti-tumor Efficacy against pancreatic cancers"

Takeshi Matsumoto (FUJIFILM Corporation)

17:00 ~ 17:35

Invited Lecture 5

"RNA technologies to control cell fate"

Hirohide Saito (CiRA, Kyoto University)

17:35~ 17:45

Awards ceremony

18:00 ~ 20:00

Banquet
bottom of page